A federal court judge has refused to issue a temporary restraining order against the secretary of the U.S. Department of Health and Human Services to halt competitive bidding for clinical laboratory services in Southern California. Three health care service providers had sued to stop the program, claiming it would damage their businesses if they lost.
Sanofi-Aventis has filed suit against syringe maker Safety Syringes Inc. in an attempt to defend itself against patent infringement allegations that are part of a different lawsuit Safety Syringes has filed.
As pharmaceutical company Baxter International Inc. investigates the four deaths and scores of allergic reactions linked to its blood thinner heparin, news that the drug's active ingredient was likely made in a Chinese factory has raised now-familiar concerns about the safety of Chinese exports, and complex questions of who's on the hook when pharmaceuticals are found to be toxic.
Allegations that Sanofi-Aventis Pharmaceuticals deliberately concealed potential harmful effects of its antibiotic Ketek, which has been linked to liver damage, continued to pile up Tuesday as the U.S. House Committee on Energy and Commerce heard more witnesses.
In another stinging setback for Boston Scientific Corp., a federal judge has handed more than $69 million in pretrial interest to a radiologist on top of an earlier jury award of $432 million in his stent patent case.
Tissue Extraction Devices LLC has filed a lawsuit against Hologic Inc. and a subsidiary, alleging that a line of breast biopsy systems infringe a recently issued patent.
The U.S. Federal Trade Commission has filed a lawsuit against Cephalon Inc. that alleges the pharmaceutical company paid off four would-be generics competitors to keep them out of the $800 million annual U.S. market for Cephalon's narcolepsy drug Provigil until 2012.
A Chinese factory that hadn't been inspected by the U.S. Food and Drug Administration manufactured the active ingredient in Heparin, a popular blood thinner that allegedly killed four people and caused allergic reactions in hundreds more, once again bringing into question the safety of drugs imported to the U.S.
A district court judge has chucked a lawsuit attempting to hold a Smith & Nephew Inc. salesman liable for marketing a defective knee implant, finding that the named defendant did not actually sell the device to the plaintiff's doctor.
Novartis International AG now has two patent suits pending against generics maker Teva Pharmaceuticals USA Inc. over the blockbuster hypertension drug Lotrel, lodging a new complaint after Teva submitted a bid to make its proposed generic in different dosage strengths.
Caremark Rx LLC has reached a settlement with 28 states and the District of Columbia, under which the pharmacy benefit management company agreed to pay $41 million to put to rest claims of deceptive business practices.
A new study has found that Bayer AG's blood-clotting drug Trasylol, which has been suspected of causing kidney damage and death in some cases, appears to be safe for some heart patients.
A judge has thrown out a lawsuit brought by several counties in Arkansas alleging that Pfizer Inc. and other drug companies failed to take steps to stop people from using cold remedies containing ephedrine and pseudoephedrine to make methamphetamine.
Novartis AG's oral fungal infection treatment Lamisil appears to put patients at risk of serious, and even life-threatening, liver, blood and skin problems, an Australian health regulator has reported.
A proposed federal class action against pharmaceutical giant Abbott Laboratories Inc. alleging a violation of overtime requirements under California law will be allowed to move forward.
Johnson & Johnson voluntarily recalled 32 million of its Duragesic pain patches on Tuesday after discovering a defect in them that could cause a fatal overdose on fentanyl, the opioid contained in the patches.
After months of fighting, Eli Lilly & Co. has won its bid to combine a California whistleblower case alleging it marketed its blockbuster anti-psychotic drug Zyprexa for off-label uses with a separate multidistrict litigation pending in a New York district court.
Heart valve manufacturer Edwards Lifesciences Corp. has stepped up its patent infringement claims against rival CoreValve Inc. by adding a U.S. suit to pending infringement claims in Europe.
The U.S. Food and Drug Administration has failed to remove criminals from the drug regulatory process and has risked the health of countless lives, according to a staff report issued Monday by House Republicans.
Sanofi-Aventis has signed a deal with a Massachusetts biopharmaceutical company granting the French pharmaceutical giant the exclusive worldwide license to an antibody that may potentially be used in treating cancer.